Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel,…
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
– BRTX-100 is the first and only stem cell product candidate cleared…
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
January 20, 2025 19:00 ET | Source: Disc Medicine Inc WATERTOWN, Mass.,…
Synergy Quantum Provides World’s Most Advanced QRNG to C-DAC, Driving India’s Quantum-Ready Future
NEW DELHI, Dec. 16, 2024 /PRNewswire/ -- Synergy Quantum, a global leader in…
